Allen Nunnally is vice president of corporate and business development at Voyager Therapeutics, Inc. His life sciences experience spans more than 16 years with a focus on genetically- and genomically-driven technologies and biopharmaceuticals at organizations ranging from Fortune 500 pharma companies to early-stage biotechs. Prior to Voyager, Mr. Nunnally served as vice president of corporate and business development and associate general counsel at Foundation Medicine, where he led transactions relating to its biopharmaceutical business in companion diagnostics, comprehensive genomic profiling, clinical trials solutions, and molecular information products and directed the company’s intellectual property strategy. Mr. Nunnally represented Foundation Medicine from Series B financing through its IPO and co-led the R&D collaboration of the company’s strategic transaction with Roche. Mr. Nunnally previously spent 10 years at the law firm Wilmer, Cutler, Pickering, Hale and Dorr LLP.
Mr. Nunnally received a B.A. in biology and law, jurisprudence and social thought from Amherst College and a JD from Boston University School of Law, where he concentrated in intellectual property law.